WednesdayJan 17, 2024 4:33 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Talks 2024 Outlook in Recent Proactive Interview

Diamond Lake Minerals (OTC: DLMI), a leading player in the digital asset landscape bridging the gap between traditional finance and decentralized finance, is featured in a recent interview released from Proactive. During the interview, Diamond Lake Minerals CEO Brian J. Esposito talked with Proactive host Steve Darling about the company’s plans for 2024. During the discussion, Esposito explained that Diamond Lake Minerals employs an innovative approach, operating as a parent umbrella conglomerate with multiple subsidiaries spanning various industries. Esposito noted that the company goal is to emulate the structure of General Electric, which is recognized for its diversified portfolio across industries. Esposito…

Continue Reading

WednesdayJan 17, 2024 3:50 pm

QualityStocksNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Engages IBN for Corporate Communications Expertise

Astrotech (NASDAQ: ASTC) is an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications around the world. The company today announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Astrotech continues to expand its ATi Mass Spectrometer Technology into new markets and recently launched its newest Pro-Control-1000(TM) product line of instrumentation designed to improve chemical manufacturing efficiencies. Astrotech also announced the formation of its newest wholly owned subsidiary, Pro-Control Inc., which has an…

Continue Reading

WednesdayJan 17, 2024 3:42 pm

QualityStocksNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB), Solar360 Join Together in ‘Disruptive’ Proposition to Revolutionize Solar Self-Consumption

Turbo Energy S.A. (NASDAQ: TURB), a leader in the field of photovoltaic energy storage, is joining with Solar360 in what it calls “a disruptive proposition in the solar photovoltaic self-consumption sector” designed to “maximize user savings and provide energy when it is needed, not just when the sun is shining.” According to the announcement, Turbo Energy will serving as a technology provider and Solar360 will act as an energy services promoter in the strategic alliance. Solar360 will install intelligent batteries produced by Turbo Energy in homes, commercial areas and industries across the country. Called Sunbox, Solar360 has already launched the…

Continue Reading

WednesdayJan 17, 2024 2:29 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Present at 26th Annual Needham Growth Conference

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will be participating in this month’s Needham Growth Conference. D-Wave, which is the world’s first commercial supplier of quantum computers, will be represented at the conference by CEO Alan Baratz and CFO John Markovich, who are slated to present at 3 p.m. ET on Jan. 19, 2024. A recording of the presentation will be available on the company’s website following the presentation. In addition, members of the D-Wave management team will be available for one-on-one meetings with investors. To view the presentation, visit https://ibn.fm/cJ6Lg To view…

Continue Reading

WednesdayJan 17, 2024 2:02 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on 2023 Financial Results, Provides Business Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a report on its financial results for the 12-month period ended Sept. 30, 2023; the company also reported on its current business operations. In the report, the company noted key achievements throughout the year, including the company recording its first revenues of $366,000 and delivering vehicles valued at $652,200 to Randy Marion Automotive for resale in September; the production of Class 3 (the Mullen THREE) vehicles beginning in August 2023 and production Class 1 (the Mullen ONE) beginning in November 2023; and by year-end delivering 100 Class 1…

Continue Reading

WednesdayJan 17, 2024 9:49 am

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Announces Participation at Sequire Investor Summit in Puerto Rico

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month’s Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and investors. The event agenda features more than 40 presentations from leading public companies as well as panel discussions and interactive sessions focused on addressing the latest trends and innovations in investor relations and technology. Puerto Rico was chosen as the site because it is home…

Continue Reading

TuesdayJan 16, 2024 3:43 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen Five RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint.” The article provided a background look at Mullen, which was incorporated in 2014 and comprises pieces of Coda Motor Cars and Mullen Motors. Calling the Five RS…

Continue Reading

TuesdayJan 16, 2024 3:12 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

Continue Reading

TuesdayJan 16, 2024 2:48 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Third-Quarter 2024 Financial Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting on its financial results for the third quarter of fiscal 2024, the period ended Nov. 30, 2023. Numbers to note from the report include quarterly revenue of $6.14 million, which includes the company’s SMS & MMS, Telecommunications Products & Services businesses as well as Big Data, totaled $5.26 million, or 46% decrease, compared to Q3 2023; a quarterly decrease in Telecommunications Products & Services business revenue of $4.22 million or 41% compared to Q3 2023; quarterly Big Data revenue of $.01 million compared to $.19 million in Q3 2023;…

Continue Reading

TuesdayJan 16, 2024 2:37 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered